CN106418553A - Milk gamma globulin immune capsules and preparation method thereof - Google Patents
Milk gamma globulin immune capsules and preparation method thereof Download PDFInfo
- Publication number
- CN106418553A CN106418553A CN201610840873.2A CN201610840873A CN106418553A CN 106418553 A CN106418553 A CN 106418553A CN 201610840873 A CN201610840873 A CN 201610840873A CN 106418553 A CN106418553 A CN 106418553A
- Authority
- CN
- China
- Prior art keywords
- gamma globulin
- vitamin
- capsule
- parts
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 31
- 108010074605 gamma-Globulins Proteins 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 235000013336 milk Nutrition 0.000 title abstract 6
- 239000008267 milk Substances 0.000 title abstract 6
- 210000004080 milk Anatomy 0.000 title abstract 6
- 230000036039 immunity Effects 0.000 claims abstract description 21
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 16
- 102000004407 Lactalbumin Human genes 0.000 claims abstract description 13
- 108090000942 Lactalbumin Proteins 0.000 claims abstract description 13
- 235000021241 α-lactalbumin Nutrition 0.000 claims abstract description 12
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims abstract description 8
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 8
- 244000068988 Glycine max Species 0.000 claims abstract description 8
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 8
- 240000008415 Lactuca sativa Species 0.000 claims abstract description 8
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims abstract description 8
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 8
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims abstract description 8
- 239000000843 powder Substances 0.000 claims abstract description 8
- 235000012045 salad Nutrition 0.000 claims abstract description 8
- 235000019155 vitamin A Nutrition 0.000 claims abstract description 8
- 239000011719 vitamin A Substances 0.000 claims abstract description 8
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 8
- 239000011718 vitamin C Substances 0.000 claims abstract description 8
- 229940045997 vitamin a Drugs 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 210000000481 breast Anatomy 0.000 claims description 11
- 108010010803 Gelatin Proteins 0.000 claims description 10
- 229920000159 gelatin Polymers 0.000 claims description 10
- 239000008273 gelatin Substances 0.000 claims description 10
- 235000019322 gelatine Nutrition 0.000 claims description 10
- 235000011852 gelatine desserts Nutrition 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000003921 oil Substances 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 5
- 239000004568 cement Substances 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 2
- 239000010687 lubricating oil Substances 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 238000005453 pelletization Methods 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 210000000582 semen Anatomy 0.000 claims description 2
- 230000008961 swelling Effects 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 240000006509 Gynostemma pentaphyllum Species 0.000 abstract 1
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- 241000825107 Hierochloe Species 0.000 description 2
- 235000015466 Hierochloe odorata Nutrition 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 208000033065 inborn errors of immunity Diseases 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 206010001497 Agitation Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000050051 Chelone glabra Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000167880 Hirundinidae Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 150000005693 branched-chain amino acids Chemical class 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000002562 urinalysis Methods 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39508—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from milk, i.e. lactoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A61K2039/507—Comprising a combination of two or more separate antibodies
Abstract
The invention discloses milk gamma globulin immune capsules and a preparation method thereof. The milk gamma globulin immune capsules comprise capsule housings and contents, wherein the contents are made from the following raw materials in parts by weight: 30-60 parts of milk gamma globulin, 10-30 parts of alpha-lactalbumin, 20-40 parts of vitamin C, 0.5-2 parts of vitamin A, 2-5 parts of gynostemma pentaphyllum, 1-5 parts of radix glycyrrhizae preparata powder and 70-120 parts of soybean salad oil. The milk gamma globulin immune capsules disclosed by the invention are neat and artistic, easy to swallow, uniform in color and free from obvious bubbles, and besides, natural active ingredients are added, so that the milk gamma globulin immune capsules are quite effectively on enhancing immunity.
Description
Technical field
The present invention relates to a kind of breast gamma globulin immunity capsule and preparation method thereof, belong to medicine and field of health care products.
Background technology
Immunity is the defense mechanism of human body itself, is human bioequivalence and any foreign body eliminating external intrusion（Viral, thin
Bacterium etc.）, process aging, damage, the dead, own cells of degeneration and identification and process vivo mutations cell and virus infect carefully
The ability of born of the same parents.Immunology Today is thought, immunity is human bioequivalence and the physiological reaction of exclusion " dissident ".This is executed in human body
Function is immune system.
The body of hypoimmunity is easy to infected or cancer stricken；Immunity is extraordinary also to produce insalubrious knot
Really, as caused anaphylaxiss, autoimmune disease etc..
A variety of causes makes immune system can not normally play protective effect, in the case, easily cause antibacterial, virus,
Funguses etc. infect, and therefore hypoimmunity the most directly shows is exactly liable to illness.Because often ill, increase disappearing of body
Consumption, thus typically have a delicate constitution, reductions of malnutrition, lethargy, fatigue and weak, appetite, the performance such as sleep disorder, give birth to
Disease, having an injection to take medicine has become homely food.Sick every time will be lot more time to recover, and usually recurrent exerbation.Grow this
Body and intelligent development can be led in the past bad, also easily induced major disease.
Gamma globulin contains the various antibody that healthy population serum has, and is combined with antibacterial, virus and toxin, is allowed to
Lose function of causing a disease, have treatment, inhibitory action to inflammation, tumor etc., thus have enhancing body resistance with pre- aseptic work
With.
Alpha-lactalbumin is the fabulous source of essential amino acids and branched-chain amino acid, is also uniquely can be with metallic element and calcium
The whey protein fraction that element combines.Nearest research more finds, it is likely to be of anti-cancer function.In addition lactalbumin is in amino
Acid ratio example configuration aspects, and all closely similar with human milk on functional characteristic.Energy enhance immunity, reduces disease and occurs.
More preferably digest and assimilate, mitigate kidney burden.Promote calcium absorption, lift effect of supplemented calcium.Containing abundant tryptophan（Happy factors）, sleep
Dormancy, emotion are more preferable, appetite stimulator.
Also do not have to prepare enhance immunity medicine using gamma globulin and alpha-lactalbumin as primary raw material at present
Report.
Content of the invention
The present invention relates to a kind of breast gamma globulin immunity capsule and preparation method thereof, it can greatly improve exempting from of human body
Epidemic disease power.
The technical scheme is that：
A kind of breast gamma globulin immunity capsule, including capsule shell and content, described content includes following weight portion
Raw material：
Newborn gamma globulin 30-60
Alpha-lactalbumin 10-30
Vitamin C 20-40
Vitamin A 0.5-2
Herb Gynostemmae Pentaphylli 2-5
Radix Glycyrrhizae Preparata powder 1-5
Soybean salad oil 70-120
More preferably, described content includes the raw material of following weight portion：
Newborn gamma globulin 30-60
Alpha-lactalbumin 10-30
Vitamin C 20-40
Vitamin A 0.5-2
Herb Gynostemmae Pentaphylli 2-5
Radix Glycyrrhizae Preparata powder 1-5
Soybean salad oil 70-120
The preparation method of above-mentioned breast gamma globulin immunity capsule, comprises the following steps：
A) dispensing：Take newborn gamma globulin, alpha-lactalbumin, Herb Gynostemmae Pentaphylli, Radix Glycyrrhizae Preparata powder, vitamin C, vitamin A, Semen sojae atricolor color
Oily mix homogeneously is drawn to obtain content.
b）Colloidal sol：Suitable quantity of water is fully swelling to obtain gelatin solution to take gelatin to add；Water is mixed with glycerol, heats in water-bath
To 60-80 DEG C, it is subsequently adding above-mentioned gelatin solution, stirring makes its mix homogeneously make rubber cement；Wherein gelatin is 150-200 weight
Part, glycerol is 50-80 weight portion, and the water adding in the water adding in gelatin and glycerol is total up to 150-200 weight portion；
c）Pill：Rubber cement and content are put into capsule machine and makes capsule；
d）Washing：Wash away lubricating oil with ethanol；
e）It is dried：Dry, pelletization.
It is further preferred that described step b）Middle mixing time is 1-1.5h.
It is further preferred that described step d）In ethanol be 95% ethanol.
It is further preferred that described step e）Middle drying temperature is 30-35 DEG C.
Beneficial effect
Product of the present invention is neat and artistic, easily swallows, uniform color, no substantially bubble, and with the addition of active skull cap components, to carrying
High immunity is largely effective.
Specific embodiment
Below in conjunction with specific embodiment, the present invention is described further.
Embodiment 1
By newborn gamma globulin 30kg, alpha-lactalbumin 15kg, vitamin C 20kg, vitamin A 0.5kg, Herb Gynostemmae Pentaphylli 2kg,
Radix Glycyrrhizae Preparata powder 1kg, soybean salad oil 70kg stir, deaeration, and capsule, every 500mg of capsule are made in last fill.
Embodiment 2
By newborn gamma globulin 45kg, alpha-lactalbumin 20kg, Catergen 5kg, retinol1 kg, Herb Gynostemmae Pentaphylli 4kg, process sweet
Grass meal 3kg, soybean salad oil 80kg stir, deaeration, and soft capsule, every 500mg of capsule are made in last fill.
Embodiment 3
By newborn gamma globulin 50kg, alpha-lactalbumin 22kg, Catergen 8kg, retinol1 kg, Herb Gynostemmae Pentaphylli 4kg, process sweet
Grass meal 3kg, soybean salad oil 90kg stir, deaeration, and capsule, every 500mg of capsule are made in last fill.
Toxicity test
This experiment adopts healthy SD rat, and the drug dose gradient of oral administration embodiment 1-3 preparation is 0.01g/kg
And 0.1g/kg, successive administration 30 days, it is observed that animal growth state, activity drink within 1 week during rat administration and after being discontinued
Food, hematology, blood biochemical analysis, organ tissue structure and routine urinalysis etc. all have no significant effect, and show that clinical application safely may be used
Lean on.
Result on trial：
In being embodied as operation, invite 80 frequent emotions agitations, anxiety, recurrent exerbation of catching a cold, work not hard, warp
The sub-health population grouping experiment often feeling exhausted.The results are shown in Table one
| Group project | Number of cases（People） | Cycle（My god） | Total effective rate（%） |
| Matched group | 20 | 30 | 0 |
| Embodiment 1 | 20 | 30 | 90 |
| Embodiment 2 | 20 | 30 | 95 |
| Embodiment 3 | 20 | 30 | 98 |
Can be obtained by upper table one, continuously foretaste embodiment 1-3 immunity capsule after one month, compare matched group（Do not eat immune glue
Capsule）, embodiment 1,2,3 groups of total effective rate significantly improves.Show that present invention breast gamma globulin immunity capsule has aobvious
The enhance immunity effect writing.
Claims (6)
1. a kind of breast gamma globulin immunity capsule is it is characterised in that include capsule shell and content, described content bag
Include the raw material of following weight portion：
Newborn gamma globulin 30-60
Alpha-lactalbumin 10-30
Vitamin C 20-40
Vitamin A 0.5-2
Herb Gynostemmae Pentaphylli 2-5
Radix Glycyrrhizae Preparata powder 1-5
Soybean salad oil 70-120.
2. according to claim 1 breast gamma globulin immunity capsule it is characterised in that described content include following heavy
The raw material of amount part：
Newborn gamma globulin 30-60
Alpha-lactalbumin 10-30
Vitamin C 20-40
Vitamin A 0.5-2
Herb Gynostemmae Pentaphylli 2-5
Radix Glycyrrhizae Preparata powder 1-5
Soybean salad oil 70-120.
3. the preparation method of the newborn gamma globulin immunity capsule described in claim 1 or 2 is it is characterised in that include following walking
Suddenly：
A) dispensing：Take newborn gamma globulin, alpha-lactalbumin, Herb Gynostemmae Pentaphylli, Radix Glycyrrhizae Preparata powder, vitamin C, vitamin A, Semen sojae atricolor color
Draw oily mix homogeneously, vacuum defoamation obtains content；
b）Colloidal sol：Suitable quantity of water is fully swelling to obtain gelatin solution to take gelatin to add；Water is mixed with glycerol, is heated in water-bath
60-80 DEG C, it is subsequently adding above-mentioned gelatin solution, stirring makes its mix homogeneously make rubber cement；Wherein gelatin is 150-200 weight portion,
Glycerol is 50-80 weight portion, and the water adding in the water adding in gelatin and glycerol is total up to 150-200 weight portion；
c）Pill：Rubber cement and content are put into capsule machine and makes capsule；
d）Washing：Wash away lubricating oil with ethanol；
e）It is dried：Dry, pelletization.
4. the preparation method of breast gamma globulin immunity capsule according to claim 3 is it is characterised in that described step b）
Middle mixing time is 1-1.5h.
5. the preparation method of breast gamma globulin immunity capsule according to claim 3 is it is characterised in that described step d）
In ethanol be 95% ethanol.
6. the preparation method of breast gamma globulin immunity capsule according to claim 3 is it is characterised in that described step e）
Middle drying temperature is 30-35 DEG C.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2016107136552 | 2016-08-24 | ||
| CN201610713655 | 2016-08-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106418553A true CN106418553A (en) | 2017-02-22 |
Family
ID=58167441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610840873.2A Pending CN106418553A (en) | 2016-08-24 | 2016-09-22 | Milk gamma globulin immune capsules and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106418553A (en) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1174742A (en) * | 1997-08-06 | 1998-03-04 | 上海科星生物技术有限公司 | Complex cow's milk gamma globulin and the making method thereof |
| CN1545922A (en) * | 2003-07-31 | 2004-11-17 | 余国华 | Gamma globulin health food (SARS health food) and manufacturing process thereof |
| CN1557489A (en) * | 2004-01-15 | 2004-12-29 | 高春平 | Preparation of oral administered immune globulin from whey |
| CN1939537A (en) * | 2005-09-27 | 2007-04-04 | 程国根 | Production of gamma immune protein capsules |
| CN101301078A (en) * | 2008-05-29 | 2008-11-12 | 陈西喆 | Nutrient health care food and preparation process thereof |
| CN102551073A (en) * | 2012-02-22 | 2012-07-11 | 浙江康恩贝健康产品有限公司 | Nutritional composition containing alpha-lactoalbumin and lactoferrin and application of nutritional composition |
| CN103349125A (en) * | 2013-07-22 | 2013-10-16 | 北京绿源求证科技发展有限责任公司 | Health-preserving food tea granule capable of improving sleeping |
-
2016
- 2016-09-22 CN CN201610840873.2A patent/CN106418553A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1174742A (en) * | 1997-08-06 | 1998-03-04 | 上海科星生物技术有限公司 | Complex cow's milk gamma globulin and the making method thereof |
| CN1545922A (en) * | 2003-07-31 | 2004-11-17 | 余国华 | Gamma globulin health food (SARS health food) and manufacturing process thereof |
| CN1557489A (en) * | 2004-01-15 | 2004-12-29 | 高春平 | Preparation of oral administered immune globulin from whey |
| CN1939537A (en) * | 2005-09-27 | 2007-04-04 | 程国根 | Production of gamma immune protein capsules |
| CN101301078A (en) * | 2008-05-29 | 2008-11-12 | 陈西喆 | Nutrient health care food and preparation process thereof |
| CN102551073A (en) * | 2012-02-22 | 2012-07-11 | 浙江康恩贝健康产品有限公司 | Nutritional composition containing alpha-lactoalbumin and lactoferrin and application of nutritional composition |
| CN103349125A (en) * | 2013-07-22 | 2013-10-16 | 北京绿源求证科技发展有限责任公司 | Health-preserving food tea granule capable of improving sleeping |
Non-Patent Citations (1)
| Title |
|---|
| 闫丽霞: "《药物制剂技术》", 31 August 2012, 华中科技大学出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN107668459A (en) | A kind of solid beverage of mushroom small-molecular peptides compounding and preparation method thereof | |
| CN104799055A (en) | Broiler feed | |
| TW201216980A (en) | Compositions and methods for treating hepatitis virus infection | |
| CN101306105B (en) | Medicament for preventing and treating puerperal hypogalactia | |
| CN107951025A (en) | A kind of Chinese medicine health-care composition for health of losing weight | |
| CN101569412B (en) | Sports nutrition supplement and application thereof | |
| US10821149B2 (en) | Composition and the use thereof | |
| CN109757733A (en) | A kind of oral polypeptide powder and its preparation method and application | |
| CN107348365A (en) | A kind of new natto polypeptide health care food | |
| CN107616402A (en) | A kind of solid beverage of black rice small-molecular peptides compounding and preparation method thereof | |
| CN104522572A (en) | Radix puerariae powder capable of supplementing qi and benefit spleen | |
| CN105663204A (en) | Composition and preparation capable of improving immune function, resisting fatigue and treating cold as well as preparation method and application of composition | |
| CN102028230B (en) | Health care product auxiliary material and application thereof | |
| CN110326776A (en) | A kind of integration of drinking and medicinal herbs compound formulation of the raising immunity of suitable spacefarer | |
| CN104082656B (en) | Nutrient meal suitable for patient with liver disease and manufacturing method thereof | |
| CN109846046A (en) | A kind of mannose-amino acid complex improving immunity | |
| CN105231461A (en) | Body immunity-improving nutrient composition and application thereof | |
| CN106418553A (en) | Milk gamma globulin immune capsules and preparation method thereof | |
| CN104855969A (en) | Non-whole nutrient formula food for liver diseases | |
| CN103798596B (en) | Total nutrient formula food suitable for patients with cardiovascular and cerebrovascular diseases | |
| CN103947816A (en) | Selenium-rich chewing gum | |
| CN109805235A (en) | A kind of drop four high wheat perfume (or spice) complex polypeptide solid beverages, Preparation method and use | |
| CN104606627B (en) | A kind of pharmaceutical composition for treating grice diarrhoea and preparation method thereof | |
| WO2013009194A1 (en) | Food supplement having high immunological value, based on a protein matrix | |
| CN103271992B (en) | Pharmaceutical composition for improving immunity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170222 |